Medicare Enrolled
Dr. Levi Deters, MD
Urology Physician · Spokane, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Deters from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deters?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Deters
Dr. Levi Deters is an urology physician in Spokane, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Deters performed 1,899 Medicare services across 1,558 unique beneficiaries.
Between the years covered by Open Payments, Dr. Deters received a total of $6,205 from 51 pharmaceutical and/or device companies across 202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Deters is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in WA
$6,205 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,899
Medicare services
Top 26% in WA for urology physician
1,558
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~100 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
488 | $8 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
277 | $94 | $242 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
195 | $66 | $167 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
136 | $190 | $513 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
130 | $3 | $33 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
97 | $117 | $348 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
62 | $19 | $54 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
42 | $260 | $492 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
39 | $83 | $443 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
39 | $102 | $300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $63 | $150 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $40 | $131 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
32 | $95 | $250 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
31 | $19 | $75 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
26 | $8 | $21 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $135 | $391 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
20 | $279 | $876 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
19 | $200 | $866 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $91 | $243 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
16 | $18 | $45 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
14 | $297 | $667 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
14 | $6 | $189 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $70 | $244 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
13 | $17 | $75 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
13 | $210 | $575 |
| Intraoperative ultrasound guidance Use of ultrasound imaging during a surgical procedure to help guide the surgeon's actions. |
13 | $48 | $171 |
| New patient office visit, complex (60-74 min) | 13 | $155 | $469 |
| Endoscopic removal of kidney and partial ureter This procedure involves removing the kidney and a portion of the ureter using an endoscope, a thin tube with a camera inserted into the body. |
12 | $956 | $2,698 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
11 | $26 | $400 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $194 | $618 |
| Laparoscopic partial prostate removal A minimally invasive surgical procedure to remove part of the prostate gland using a laparoscope. |
11 | $796 | $3,202 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.3% high complexity
31.0% medium
63.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,205
Total received (2018-2024)
Avg $886/year across 7 years
Top 19% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
202
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,677 (91.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$472 (7.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,024
2023
$714
2022
$824
2021
$1,185
2020
$278
2019
$872
2018
$1,309
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$289
Dendreon Pharmaceuticals LLC
$172
Janssen Biotech, Inc.
$86
Sumitomo Pharma America, Inc.
$83
ACCORD HEALTHCARE, INC.
$62
Merck Sharp & Dohme LLC
$60
Boston Scientific Corporation
$55
SUN PHARMACEUTICAL INDUSTRIES INC.
$33
Blue Earth Diagnostics Limited
$31
180 Medical, Inc.
$29
Astellas Pharma US Inc
$23
Endo Pharmaceuticals Inc.
$23
PROGENICS PHARMACEUTICALS, INC.
$22
Tolmar, Inc.
$21
IMMUNITYBIO, INC.
$21
AstraZeneca Pharmaceuticals LP
$16
Top 3 companies account for 53.4% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$704
UROGEN PHARMA, INC.
$472
Astellas Pharma US Inc
$409
Bayer HealthCare Pharmaceuticals Inc.
$340
Janssen Biotech, Inc.
$333
ABBVIE INC.
$332
AbbVie, Inc.
$264
Olympus America Inc.
$257
Sumitomo Pharma America, Inc.
$237
AbbVie Inc.
$217
BOSTON SCIENTIFIC CORPORATION
$209
Boston Scientific Corporation
$199
Rochester Medical Corporation
$183
KARL STORZ Endoscopy-America
$148
NeoTract Inc.
$143
PFIZER INC.
$142
Teleflex LLC
$132
Analogic Corporation
$127
Merck Sharp & Dohme LLC
$117
Allergan, Inc.
$96
ACCORD HEALTHCARE, INC.
$94
Myriad Genetic Laboratories, Inc.
$92
Endo Pharmaceuticals Inc.
$76
Ambu Inc.
$70
Myovant Sciences Inc.
$65
TOLMAR Pharmaceuticals, Inc.
$58
Amgen Inc.
$56
Sun Pharmaceutical Industries Inc.
$55
Allergan Inc.
$55
UROVANT SCIENCES INC
$49
Coloplast Corp
$48
BAXTER HEALTHCARE
$45
SUN PHARMACEUTICAL INDUSTRIES INC.
$33
Photocure Inc
$33
Blue Earth Diagnostics Limited
$31
180 Medical, Inc.
$29
Baxter Healthcare
$23
Novartis Pharmaceuticals Corporation
$23
PROGENICS PHARMACEUTICALS, INC.
$22
Tolmar, Inc.
$21
IMMUNITYBIO, INC.
$21
ConvaTec Inc.
$18
Ethicon US, LLC
$18
UroGen Pharma, Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
COLOPLAST CORP
$16
Alnylam Pharmaceuticals Inc.
$15
Kowa Pharmaceuticals America, Inc.
$14
Medtronic USA, Inc.
$13
UroMed, Inc.
$12
Travere Therapeutics, Inc.
$8
Top 3 companies account for 25.6% of all-time payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · ADVANCE · AMS · ANKTIVA · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · BRACAnalysis CDx · BRIDION · CAMCEVI · Coloplast TFL Drive · Cysview · ELIGARD · ERLEADA · GEMTESA · GENERAL - ONCOLOGY · GENTLECATH GLIDE · GentleCath · HD CAMERA HEAD · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Nubeqa · ORGOVYX · OXLUMO · Olympus Camera Heads · Olympus Digital Flexible Ureteroscopes · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Prolaris · Prolia · SUTENT · Seglentis · ShockPulse - SE · Surgicel Powder · TISSEEL · Thiola · ThunderBeat · Titan · URETERO-RENO VIDEOSCOPE · UROLIFT · UroLift · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · n.a.
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
23
Per 100K population
4.2
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Deters is a clinical cardiology specialist, with above-average Medicare volume (top 26% in WA), with low-engagement industry engagement in the top 19% of WA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Deters experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Deters performed 488 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deters receive payments from pharmaceutical companies?
Yes. Dr. Deters received a total of $6,205 from 51 companies across 202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deters's costs compare to other urology physicians in Spokane?
Dr. Deters's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deters) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Spokane
Browse urology physicians in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in WA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in WA
Which WA urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
UROGEN PHARMA, INC. Payments to Doctors
See all physicians who received payments from UROGEN PHARMA, INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology